Abstract The development of dual agonists for the glucagon-like peptide-1 receptor (GLP-1R) and glucose-dependent insulinotropic polypeptide receptor (GIPR) has been a landmark moment in the treatment of type 2 diabetes and obesity
The STEP (Semaglutide Treatment Effect in People with obesity) clinical trial programme, which established Wegovy's effectiveness, allowed participants to use any approved injection site
For patients who struggle most with hunger and portion control, Phentermine is a proven appetite suppressant that curbs cravings and supports faster progress
Mu, Q., Kirby, J., Reilly, C
If you have concerns about the ingredients in your medication or experience unexpected symptoms, consult your GP or pharmacist, who can provide detailed information about the formulation and address any specific worries you may have regarding your treatment
Tirzepatide is a new drug that has shown promising results in clinical trials for weight loss